Netherlands
Intelligence de marché des dispositifs médicaux pour Netherlands. Changements réglementaires, concurrents et tendances d'achats.
Table pays dernière MAJ : 7 août 2026 (peut être en retard). Le total 7 j est recalculé en direct (ancienne valeur table : 45).
Signaux des 7 derniers jours
Draft guideline on the requirements for demonstrating therapeutic equivalence for nasal products
Clinical trial applications advice pilot becomes permanent
Quality, preclinical and clinical aspects of gene therapy medicinal products - Scientific guideline - European Medicines Agency (EMA)
Physical frailty: instruments for baseline characterisation of older populations in clinical trials - Scientific guideline - European Medicines Agency (EMA)
Medical devices legislation - European Medicines Agency (EMA)
Concept paper on the guideline revision on good pharmacogenomic practice
Clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD) - Scientific guideline - European Medicines Agency (EMA)
ICH M11 guideline, clinical study protocol template and technical specifications - Scientific guideline - ema.europa.eu
EMA Public Declaration of Interests form - European Medicines Agency (EMA)
Clinical investigation of medicinal products in the treatment of lipid disorders - Scientific guideline - European Medicines Agency (EMA)
Expert decision and opinion in the context of the Clinical Evaluation Consultation Procedure (CECP) - European Medicines Agency (EMA)
Clinical evaluation of new vaccines - Scientific guideline - European Medicines Agency (EMA)
Non-clinical requirements for radiopharmaceuticals - Scientific guideline - European Medicines Agency (EMA)
Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline - European Medicines Agency (EMA)
Clinical development of fixed combination medicinal products - Scientific guideline - European Medicines Agency (EMA)
ICH E6 Good clinical practice - Scientific guideline - European Medicines Agency (EMA)
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October